BioSpace News Archive

BioCardia®, Inc. reported financial results and business highlights for the second quarter 2018 and filed its quarterly report on Form 10-Q for the three and six months ended June 30, 2018 with the Securities and Exchange Commission.

The Board of Directors of AmerisourceBergen Corporation declared a quarterly dividend of $0.38 per common share, payable September 4, 2018, to stockholders of record at the close of business on August 20, 2018.

Intrexon Corporation will host a call today to provide a general update and highlight recent business developments, as well as provide select preliminary and unaudited second quarter results.

NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today that it will host a Key Opinion Leader (KOL) event focused on novel treatment approaches for glioblastoma.

According to a new review, approximately 30 million Americans - about 15 percent of adults - have chronic kidney disease, a number that is expected to increase in the next 20 years due to rising obesity rates and longer lifespans, but the majority of chronic kidney disease patients aren’t receiving potentially lifesaving treatment.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ampio Pharmaceuticals, Inc. (“Ampio” or the “Company”) (NYSE-MKT:AMPE).